Sherbrooke Park Advisers’s Neuronetics STIM Stock Holding History

Sherbrooke Park Advisers’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,156	Closed	-$33.2K	–	507
2025 Q3	$33.2K	Buy	+12,156	New	+$43.2K	0.02%	498

Other funds holding STIM

MAM

Madryn Asset Management New York $34.1M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sherbrooke Park Advisers's STIM Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Neuronetics (STIM) in Q4 2025, closing a stake of 12,156 shares — an estimated $33.2K sold.

Sherbrooke Park Advisers first reported a position in STIM in Q3 2025 and held it in 1 quarter. The position peaked at $33.2K in Q3 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q4 2025.

Sherbrooke Park Advisers reported no remaining Neuronetics position as of Q4 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 12,156 Neuronetics shares in Q4 2025, an estimated $33.2K.
Sherbrooke Park Advisers first reported a position in Neuronetics in Q3 2025 and held it in 1 quarter.
Sherbrooke Park Advisers's Neuronetics position peaked at $33.2K in Q3 2025.
95 funds tracked by Wall St. Rank held Neuronetics as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.